Rosacea: Clinical Trials

24 trials for Rosacea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed. 24 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 424Completed 24

Follow Rosacea: new trials by email Literature Review of Rosacea trials Research Report on Rosacea

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brimonidine 0.33% for Rosacea-Related Facial Erythema
Brimonidine 0.33% gel, Placebo gel - Rosacea, Rosacea Subtype 1 (Erythematotelangiectatic)
Phase 4CompletedIstanbul Training and Research Hospital452025-05-012026-02-24
Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema
İsotretinoin - Rosacea
Phase 4CompletedSB Istanbul Education and Research Hospital302023-09-012025-03-12
Ocular Rosacea Biome Study
Doxycycline 40 MG ( 20mg twice daily), Doxycycline 200 MG ( 100 mg twice daily), Placebo - Ocular Rosacea, Antimicrobial Resistance
Phase 4CompletedUniversity of California, San Francisco462023-06-222026-10-27
Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea
Botulinum toxin A, Placebo - Erythematotelangiectatic Rosacea
Phase 4CompletedIstanbul Training and Research Hospital302022-11-012024-03-29
A Pilot Study on the Use of Seysara for Rosacea
sarecycline, Centrum Adult Multivitamin - Acne Rosacea
Phase 4CompletedDerm Research, PLLC1002019-04-152021-01-07
Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea
The Vbeam® Prima System, Oxymetazoline HCL 1% Cream - Erythematotelangiectatic Rosacea
Phase 4CompletedCandela Corporation342019-01-152022-03-31
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea
Azelaic Acid foam 15% - Rosacea, Papulopustular
Phase 4CompletedClinical Research Center of the Carolinas52017-12-062019-07-24
Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea
Oxymetazoline HCL 1.0% Cream, Energy-Based Therapy - Rosacea
Phase 4CompletedAclaris Therapeutics, Inc.462017-12-042019-09-04
Oracea Soolantra Association in Participants With Severe Rosacea
Ivermectin 1% cream, Doxycycline 40 mg MR (30 mg Immediate Release & 10 mg Delayed Release beads) capsules, Oral placebo capsules - Rosacea
Phase 4CompletedGalderma R&D2732017-07-052021-03-16
Internet Surveys and Their Impact on Adherence for Rosacea
brimonidine topical gel 0.33% & survey, brimonidine topical gel 0.33% & SOC - Rosacea
Phase 4CompletedWake Forest University Health Sciences202016-05-052018-10-10
MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.
Brimonidine 0.33% gel (Br), CD07805/47 (Br) placebo gel, Ivermectin 1% cream (IVM) - Rosacea
Phase 4CompletedGalderma R&D1902015-12-012021-02-18
Mirvaso in Use Study
Brimonidine - Rosacea
Phase 4CompletedGalderma R&D2052014-09-012022-08-01
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
Azelaic acid 15%, Brimonidine 0.33% - Acne Rosacea
Phase 4CompletedDerm Research, PLLC222014-05-012015-09-30
Photodynamic Therapy for Papulopustular Rosacea
Aminolevulinic acid topical solution 20%, Blu-U Light Therapy, Placebo vehicle only - Rosacea, Papulopustular Rosacea
Phase 4CompletedGeorge Washington University302014-04-242022-12-29
Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea
Oracea - Papulopustular Rosacea
Phase 4CompletedGalderma R&D242013-03-012022-08-23
Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Doxycycline, Metronidazole, Placebo - Rosacea
Phase 4CompletedGalderma R&D2352011-09-012022-08-01
Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo
Doxycycline, Placebo - Rosacea
Phase 4CompletedGalderma R&D1702011-04-012022-08-01
Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea
Minocycline 45 MG, Azelaic acid - Rosacea
Phase 4CompletedDermatology Specialists Research602010-05-012021-08-20
ORCA - Oracea® for Rosacea: A Community-based Assessment
doxycycline (Oracea®) 40 mg modified release as monotherapy, doxycycline (Oracea®) 40 mg modified release as add-on therapy - Rosacea
Phase 4CompletedGalderma R&D14212009-04-012022-08-25
Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea
Azelaic acid (Finacea, BAY39-6251), Metronidazole (Metrogel), Doxycycline (Oracea) - Papulopustular Rosacea
Phase 4CompletedLEO Pharma2072009-02-012020-03-31

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Telangiectasis (2)  ·  Depression (1)  ·  Erythema (1)

Broader conditions

Skin Diseases (24)  ·  Skin and Connective Tissue Diseases (24)  ·  Cardiovascular Diseases (2)  ·  Vascular Diseases (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Skin Manifestations (1)

Interventions

Doxycycline (8)  ·  azelaic acid (5)  ·  Brimonidine Tartrate (4)  ·  Gels (3)  ·  Metronidazole (3)  ·  Ivermectin (2)  ·  Oxymetazoline (2)  ·  Aminolevulinic Acid (1)  ·  Botulinum Toxins, Type A (1)  ·  Capsules (1)  ·  Intravital Microscopy (1)  ·  Isotretinoin (1)  ·  Minocycline (1)  ·  Sodium Chloride (1)  ·  Surveys and Questionnaires (1)

Sponsors

Galderma R&D (8)  ·  Derm Research, PLLC (2)  ·  Istanbul Training and Research Hospital (2)  ·  LEO Pharma (2)  ·  Aclaris Therapeutics, Inc. (1)  ·  Candela Corporation (1)  ·  Clinical Research Center of the Carolinas (1)  ·  CollaGenex Pharmaceuticals (1)  ·  Dermatology Specialists Research (1)  ·  George Washington University (1)  ·  Ophthalmic Consultants of Long Island (1)  ·  SB Istanbul Education and Research Hospital (1)  ·  University of California, San Francisco (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (20)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  Germany (1)  ·  Hungary (1)

Top investigators

Ronald W Gottschalk, MD (4)  ·  Alison Ehrlich, MD, MHS (1)  ·  Christopher V Powala, JD (1)  ·  Gerami Seitzman, MD (1)  ·  James M Jackson, MD (1)  ·  Jeffrey Sugarman, MD (1)  ·  John R Wittpenn, MD (1)  ·  Kamaria Nelson, MD (1)  ·  Konika P Schallen, MD (1)  ·  Leon H. Kircik, M.D. (1)  ·  Nancy Alvandi (1)  ·  Steve Feldman, MD (1)  ·  Todd Schlesinger, MD, FAAD (1)

Results publications

PMID 20645521, PMID 23839181, PMID 34233378, PMID 36539810